Loading...
Walgreens Boots Alliance, Inc.
W8A.DE•XETRA
HealthcareMedical - Pharmaceuticals
€9.88
€0.03(0.33%)
Walgreens Boots Alliance, Inc. (W8A.DE) Financial Performance & Statements
Review Walgreens Boots Alliance, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.17%
↑ 6.17%
Operating Income Growth
-104.53%
↓ 104.53%
Net Income Growth
-180.39%
↓ 180.39%
Operating Cash Flow Growth
-54.92%
↓ 54.92%
Operating Margin
-4.40%
↓ 4.40%
Gross Margin
17.39%
↑ 17.39%
Net Profit Margin
-3.80%
↓ 3.80%
ROE
-56.19%
↓ 56.19%
ROIC
-15.31%
↓ 15.31%
Walgreens Boots Alliance, Inc. (W8A.DE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Walgreens Boots Alliance, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $39.46B | $37.55B | $36.35B | $37.05B |
| Cost of Revenue | $32.68B | $31.29B | $29.89B | $30.01B |
| Gross Profit | $6.78B | $6.25B | $6.46B | $7.04B |
| Gross Profit Ratio | $0.17 | $0.17 | $0.18 | $0.19 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $7.01B | $6.95B | $6.39B | $7.92B |
| Operating Expenses | $7.02B | $7.23B | $6.35B | $20.21B |
| Total Costs & Expenses | $39.70B | $38.52B | $36.24B | $50.22B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $122.00M | $131.00M | $113.00M | $138.00M |
| Depreciation & Amortization | $625.00M | $622.00M | $607.00M | $614.00M |
| EBITDA | -$236.00M | -$245.00M | $971.00M | -$12.36B |
| EBITDA Ratio | -$0.006 | -$0.007 | $0.03 | -$0.33 |
| Operating Income | -$236.00M | -$977.00M | $111.00M | -$13.17B |
| Operating Income Ratio | -$0.006 | -$0.03 | $0.003 | -$0.36 |
| Other Income/Expenses (Net) | -$179.00M | -$21.00M | $140.00M | $57.00M |
| Income Before Tax | -$415.00M | -$998.00M | $251.00M | -$13.11B |
| Income Before Tax Ratio | -$0.01 | -$0.03 | $0.007 | -$0.35 |
| Income Tax Expense | $66.00M | $2.08B | $20.00M | -$782.00M |
| Net Income | -$265.00M | -$3.005B | $344.00M | -$5.91B |
| Net Income Ratio | -$0.007 | -$0.08 | $0.009 | -$0.16 |
| EPS | -$0.31 | -$3.48 | $0.40 | -$6.85 |
| Diluted EPS | -$0.31 | -$3.48 | $0.40 | -$6.85 |
| Weighted Avg Shares Outstanding | $863.80M | $863.70M | $863.10M | $862.50M |
| Weighted Avg Shares Outstanding (Diluted) | $863.80M | $863.70M | $864.30M | $862.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan